AZN reported its 4Q-2102 financial results, revenue declined by 15% while core EPS was up by 1% driven by one time tax benefits and lower operating costs. For 2013, the company has guided mid to high single digit decline in revenue, while core EPS s....
Biopharmaceuticals | Jan 31st, 2013 | by MP Advisors
TechNavio's analysts forecast the Global Dermatophytic Onychomycosis Therapeutics market to grow at a CAGR of 7.28 percent over the period 2012-2016. One of the key factors contributing to this market growth is the strong and promising pipeline. The ....
Biopharmaceuticals | Sep 13th, 2013 | by Technavio
TechNavio's analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.34 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of allergies. The Global Ep....
Biopharmaceuticals | Sep 06th, 2013 | by Technavio
Introduction to the Market
Computer-aided manufacturing (CAM) software solution provides efficient methods for manufacturing critical 2D and 3D objects with ease and better quality. It enables the calculation of tool paths based on the geometric dim....
Biopharmaceuticals | May 27th, 2013 | by Technavio
Introduction to the market
Computer-aided design (CAD) software provides an efficient, easier and cost-effective method for modeling and designing critical parts, components, and structurals with enhanced quality and accuracy. These software solutio....
Biopharmaceuticals | Apr 12th, 2013 | by Technavio
Facebook
Twitter
Google Plus
Linked In
RSS Feed
